Archiv: licensing


15.03.2020 - 22:51 [ Genetic Engineering and Biotechnology News - genengnews.com ]

CureVac, Sanofi Pasteur, and In-Cell-Art Collaborate on €33.1M DARPA-Supported Vaccine Program

(November 15, 2011)

The four-year DARPA-supported program will exploit CureVac’s RNActive technology along with In-Cell-Art’s nanoparticle expertise and Sanofi’s vaccine development capabilities.

The option agreement signed between Sanofi and CureVac in parallel with the DARPA collaboration covers pre-agreed license terms for the development of vaccines against a number of predefined pathogens.

24.08.2019 - 12:34 [ SpaceNews.com ]

Administration policies seek to promote use of space nuclear power

A revised policy for approving the launch of spacecraft with nuclear power systems is the latest measure intended to support greater use of nuclear power systems in orbit and beyond.

The policy, formally issued by President Trump Aug. 20 to coincide with the latest public meeting of the National Space Council, updates guidelines for how both government and commercial spacecraft carrying space nuclear systems are reviewed and approved for launch.

24.08.2019 - 12:32 [ Weißes Haus ]

Presidential Memorandum on Launch of Spacecraft Containing Space Nuclear Systems

This memorandum establishes processes for Federal Government launches and launches for which the Department of Transportation (DOT) has statutory authority to license as commercial space launch activities (commercial launches). These processes include transparent safety guidelines and are forward-looking and amenable to effective use of space nuclear systems for heating, power, and propulsion.